Sands Capital Alternatives, LLC
Q3 2025 13F Holdings
- Locationarlington, VA
- Num holdings
20
- Value ($000)
$456,416
- Date Filed11/13/2025
- Form type13F-HR
- CIK0001846444
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
NU NU HLDGS LTD | ORD SHS CL A | G6683N103 | $114.88 M | 25 % | 7,175,434 | ||
KVYO KLAVIYO INC | COM SER A | 49845K101 | $97.33 M | 21 % | 3,515,065 | ||
BETA BIONICS INC | COM | 08659B102 | $70.94 M | 16 % | 3,570,113 | ||
CPNG COUPANG INC | CL A | 22266T109 | $25.60 M | 6 % | 795,006 | ||
DASH DOORDASH INC | CL A | 25809K105 | $24.52 M | 5 % | 90,142 | ||
IOT SAMSARA INC | COM CL A | 79589L106 | $22.31 M | 5 % | 598,914 | ||
IKT INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | $17.74 M | 4 % | 10,950,000 | ||
DDOG DATADOG INC | CL A COM | 23804L103 | $16.90 M | 4 % | 118,707 | ||
MONDAY COM LTD | SHS | M7S64H106 | $11.30 M | 3 % | 58,336 | ||
TARS TARSUS PHARMACEUTICALS INC | COM | 87650L103 | $10.10 M | 2 % | 170,000 |
Rows Per Page
10
- 10
- 50
- 100